Android app on Google Play

Questcor (QCOR) Up on Positive Insurer Backing

October 24, 2012 11:07 AM EDT Send to a Friend
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) is tracking slightly higher Wednesday after Wellpoint told Bloomberg that Acthar is considered medically necessary for infantile spasms and there has been no change in coverage over the past year.

The news comes amid recent issues with insurer willingness to pay for the drug.

Shares of QCOR last traded at $26.08, up 0.6%.




You May Also Be Interested In


Related Categories

Trader Talk

Add Your Comment